Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,836 public trials 1,783 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC

NCT03184090

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Istituto Europeo di Oncologia Milan, Italy
  • Azienda Sanitaria Universitaria Integrata di Udine Udine, Italy
  • ICO Badalona Badalona, Barcelona, Spain
  • ICO l'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
View all 15 locations
View Trial Details
Completed

Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer

NCT03291886

Conditions
Advanced or Recurrent Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Shikoku Cancer Center Matsuyama, Ehime, Japan
  • Kitakyushu Municipal Medical Center Kitakyushu, Fukuoka, Japan
View all 28 locations
View Trial Details
Completed

Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)

NCT02574455

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Southern Cancer Center, 29653 Anchor Cross Blvd Daphne, Alabama, United States
  • Souther Cancer Center, 3719 Dauphin St., 5 Floor Mobile, Alabama, United States
  • Southern Cancer Center, 3 Mobile Infirmary Circle Mobile, Alabama, United States
  • Southern Cancer Center, 6701 Airport Blvd., Bldg B, Terace Level Mobile, Alabama, United States
View all 230 locations
View Trial Details
Completed

A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

NCT01966471

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • HonorHealth Research Institute - Bisgrove Scottsdale, Arizona, United States
  • Kaiser Permanente - Oakland Oakland, California, United States
  • Kaiser Permanente - Roseville; Oncology Pharmacy Roseville, California, United States
  • Kaiser Permanente - Sacramento; Oncology Pharmacy Sacramento, California, United States
View all 295 locations
View Trial Details
Completed

BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer

NCT02379247

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions